Upstream Bio, Inc.
NASDAQ:UPBBiotechnology
+$0.10 today
- Market cap
- $114.01M
- Beta
- 1.11
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$2.89
Volume 1.24M
Average 0.66M
UPB Total Debt
Short-term and long-term borrowings combined.
Upstream Bio, Inc.NASDAQ: UPB
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt falls 34.5% from a year ago
Total debt stood at $1.11M at the end of Q1 FY2026, down 34.5% from a year earlier and down 12.2% from the prior quarter. Over 3 fiscal years it compounded at +138.1% a year.
Context
- Total debt amounted to 0.4% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Total debt increased in 1 of the last 3 fiscal years.
What to watch
Whether total debt keeps falling in the next quarterly balance sheet after a -34.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 1.27M USD
- Year-over-year change
- -30.8%
- 3-year CAGR
- +138.1%
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.27M | -30.8% |
| FY2024 | 2024-12-31 | 1.83M | +3975.6% |
| FY2023 | 2023-12-31 | 45K | -52.1% |
| FY2022 | 2022-12-31 | 94K | — |
Total Debt vs competitors
How UPB compares with its peers on the latest reported figures
- Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -34.5% is the lowest of 9, against a peer median of -3.0%.
- Total debt amounts to 0.4% of total assets for UPB, versus a peer median of 3.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $351.73M USD | +28612.6% | +274.1% | 47.0% | |
| Mar 2026 | $345.36M USD | +18700.2% | +568.3% | 73.1% | |
| Mar 2026 | $295.06M USD | +29.0% | -23.2% | 28.3% | |
| Mar 2026 | $80.49M USD | -32.5% | -10.6% | 10.6% | |
| Jun 2026 | $30.66M USD | -10.3% | -17.5% | 3.2% | |
| Mar 2026 | $15.72M USD | -33.4% | -22.1% | 2.7% | |
| Sep 2026 | $4.94M USD | -16.7% | -1.7% | 0.6% | |
UPBUpstream Bio, Inc. | Mar 2026 | $1.11M USD | -34.5% | +138.1% | 0.4% |
| Sep 2026 | €603.94K EUR | +4.4% | +21.2% | 0.2% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UPB) | — | -3.0% | -6.2% | 3.2% | |
Competitors are the stored peer set for UPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Upstream Bio, Inc.
NASDAQ:UPB
Intrinsic Alpha fair value
Locked
Current Price
$2.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.